hidden pixel

Atipamezole Information

Atipamezole (brand name Antisedan, Pfizer) is a synthetic alpha2-adrenergic antagonist, indicated for the reversal of the sedative and analgesic effects of dexmedetomidine and medetomidine in dogs.[1] It has also been researched in humans as a potential anti-Parkinsonian drug.[2]

References

  1. ^ Pfizer Animal Health ANTISEDAN Product Overview
  2. ^ Pertovaara A, Haapalinna A, Sirviö J, Virtanen R (2005). "Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2-adrenoceptor antagonist". CNS Drug Reviews 11 (3): 273–88. doi:10.1111/j.1527-3458.2005.tb00047.x. PMID 16389294.

External links

Adrenergics
Receptor ligands
α1
α2
β
Reuptake inhibitors
NET
VMAT
Releasing agents
Enzyme inhibitors
Anabolism
PAH
TH
AAAD
DBH
PNMT
  • CGS-19281A
  • SKF-64139
  • SKF-7698
Catabolism
MAO
COMT
Others
Precursors
Cofactors
Others
List of adrenergic drugs
This veterinary medicine–related article is a stub. You can help Wikipedia by expanding it.

Categories:

 

The above information uses material from Wikipedia and is licensed under the GNU Free Documentation License.
Some facts may not have been fully verified for accuracy. [Disclaimers]
This page was last archived by our server on Mon Feb 20 18:30:36 2012.
Displaying this page or its contents does not use any Wikimedia Foundation's resources.
The owners of this site proudly support the Wikimedia Foundation.